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doi:10.1016/j.ejvs.2008.12.019Abstract Objective: Imaging follow-up (FU) after endovascular aneurysm repair (EVAR) is
usually performed by periodic contrast-enhanced computed tomography (CT) scans. This study
aims to evaluate the effectiveness of CT-FU after EVAR.
Methods: In this study, 279 of 304 consecutive patients (261 male, aged 74 years (interquartile
range (IQR): 70e79 years) with a median abdominal aortic aneurysm (AAA) diameter of 58 mm
(IQR: 53e67 mm)) underwent at least one of the yearly CT scans and plain abdominal films
after EVAR. All patients received Zenith stent-grafts for non-ruptured AAAs at a single institu-
tion. Patients were considered asymptomatic when a re-intervention was done solely due to an
imaging FU finding. The data were prospectively entered in a computer database and retro-
spectively analysed.
Results: As a follow-up, 1167 CT scans were performed at a median of 54 months (IQR: 34e74
months) after EVAR. Twenty-seven patients exhibited postoperative AAA expansion (a 5-year
expansion-free rate of 88 2%), and 57 patients underwent 78 postoperative re-interventions
with a 5-year secondary success rate of 91 2%. Of the 279 patients, 26 (9.3%) undergoing imaging
FU benefitted from the yearly CT scans, since they had re-interventions based on asymptomatic
imaging findings: AAA diameter expansion with or without endoleaks (nZ 18), kink in the stent-
graft limbs (nZ 4), endoleak type III due to stent-graft limb separation without simultaneous
AAA expansion (nZ 2), isolated common iliac artery expansion (nZ 1) and superior mesenteric
artery malperfusion due to partial coverage by the stent-graft fabric (nZ 1).
Conclusions: Less than 10% of the patients benefit from the yearly CT-FU after EVAR. Only one re-
intervention due to partial coverage of a branch by the stent-graft would have been delayed if
routine FU had been based on simple diameter measurements and plain abdominal radiograph.
This suggests that less-frequent CT is sufficient in the majority of patients, which may simplify
the FU protocol, reduce radiation exposure and the total costs of EVAR. Contrast-enhanced CT
scans continue, nevertheless, to be critical when re-interventions are planned.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.331000; fax: þ46 40 338097.
.se (N.V. Dias).
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Table I Patients’ characteristics and stent-graft configuration
Median (IQR) n (%)
Age 74 (70e79)
Gender (Male/Female) 261 (86 %)/
43 (14 %)
AAA diameter (mm) 58 (53e67)
AAA-related symptoms
Asymptomati 54 (18 %)
Symptomatic 250 (82 %)
Stent-graft configuration
Bifurcated 278 (91 %)
Aorto-uniiliac 24 (8 %)
Aorto-aortic 2 (1 %)
All stent-grafts used were Zenith (Cook Europe A/S, Bjaeverskov,
Danmark).
426 N.V. Dias et al.Endovascular aneurysm repair (EVAR) has been subject to
intensive follow-up programs since its introduction. In
contrast to open repair, EVAR relies on the remote
insertion of a stent-graft without disrupting the physical
integrity of the aneurysm wall. This has allowed the use
of the aneurysm diameter as one of the main surrogate
indicators of successful EVAR. Preventing expansion of the
aneurysm sac is, therefore, defined as one of the prin-
cipal aims of EVAR.1
Imaging follow-up after EVAR evaluates usually not
only the aneurysm size, but also the endoleak status,
stent integrity and migration of the stent-graft. Imaging
protocols, particularly when stainless-steel-based stent-
grafts are used, involve periodic contrast-enhanced spiral
computed tomography (CT) scans and plain abdominal
films. This intensive imaging follow-up provides a great
amount of information, but the relevance of the infor-
mation acquired has not been evaluated in relation to
improving results obtained with successive generations of
stent-grafts.2,3 An increasing number of periodic exami-
nations may therefore be required before an adverse
event needing re-intervention is identified. However,
repeated contrast-enhanced CT scans involve risks to the
renal function4 and have a carcinogenic potential.5
Moreover, imaging follow-up has been shown to be
a contributor to the high costs associated with EVAR.6,7
The optimisation of the follow-up protocol after EVAR is
therefore essential, especially considering that any
benefit will be amplified by the increasing use of this
technique in the treatment of abdominal aortic aneu-
rysms (AAAs)8,9 in recent years.
This study aims to evaluate the outcome of CT follow-up
in patients who underwent EVAR of AAA with a recent
generation of stent-grafts.
Methods
Patients and procedures
This study included 304 consecutive patients who were
treated for non-ruptured AAA with the standard Zenith
stent-graft (Cook Europe A/S, Bjaeverskov, Denmark)
between May 1998 and February 2006.
The patients receiving fenestrated and/or branched
stent-grafts and those undergoing EVAR of ruptured AAAs,
pseudo-aneurysms and aortic ulcers were excluded.
Anatomical suitability for EVAR included proximal neck
diameter 30 mm, angulation 90 and length 12 mm.
For distal implantation, at least one common iliac artery
with a distal diameter 20 mm was required. Table I
describes the patient characteristics and stent-grafts used.
Follow-up after EVAR
Postoperative follow-up included clinical assessment at 1
and 12 month(s) after EVAR. The imaging follow-up con-
sisted of periodic contrast-enhanced CT scans and plain
abdominal films. The periodicity of the examinations
changed during the study period, but all protocols included
at least yearly imaging. The CT scans were obtained at 1, 3
and 6 month(s) postoperatively and every half yearthereafter until the year 2000. Subsequently, the CT scans
were performed at 1 month and yearly thereafter. Since
2002, the need for a 1-month CT scan was left to the
discretion of the operator.
The AAA diameters were measured in axial CT scans
perpendicular to the maximum diameter in order to avoid
errors caused by vessel tortuosity. The AAA shrinkage or
expansion was defined when the diameter decreased or
increased by 5 mm or more, respectively.1
Considering the changes in our follow-up protocol,
yearly CT scans were assumed for the analysis of the
outcome. The end-points for the follow-up included the
following: freedom from AAA expansion and rupture or AAA-
related death and the performance of re-interventions on
an elective basis before the development of symptoms.
Benefit from CT follow-up was assumed whenever adverse
events were identified at an earlier stage than if routine
imaging follow-up had not been performed. Asymptomatic
patients undergoing re-interventions prompted by a CT
finding without AAA expansion would not have been offered
a re-intervention based solely on clinical symptoms and
simple diameter measurements. Primary clinical success
was defined according to the reporting standards.1 The
definition of secondary success was simplified by assuming
all re-interventions that allowed the maintenance of clin-
ical success, independently of the technique used (endo-
vascular or open).
Study setting, data collection and presentation
The study was conducted at a university tertiary referral
centre. Data from all patients undergoing EVAR of AAA were
prospectively entered into a database. Patients fulfilling
the inclusion criteria were retrospectively selected for the
study. The study was approved by the local ethical
committee and the patients gave their informed consent
before the procedures.
The values for continuous variables are shown as median
(interquartile range (IQR)). Survival was calculated using
life-tables and is presented as mean standard deviation.
Survival plots were based on KaplaneMeyer curves. Non-
parametric tests were used for comparisons, with a signifi-
cance level of p< 0.05. The SPSS 16.0.1 software (SPSS
Inc., Chicago, IL, USA) was used.
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Study population
Of the 304 patients, 279 were available for the yearly CT
follow-up (Fig. 1). Two of the 25 patients who could not
undergo a 1-year CT follow-up had been converted to open
repair. One conversion was successfully done intra-opera-
tively due to an incomplete stent-graft deployment in
a severely angled suprarenal aorta that impaired the
deployment of the top cap. The other conversion to open
repair followed thedevelopment of an aorto-duodenal fistula
2 months after EVAR of a rapidly expanding painful AAA. This
patient died in-hospital 1.5 months after the conversion and
was therefore considered as an AAA-related death.
Mortality
The other 23 patients who could not undergo 1-year post-
operative CT scan had died: nine within 30 days (3%) and 14
at 1e12 months of unrelated causes. During the rest of the
study period (more than 1 year of follow-up), there was
only one additional AAA-related death due to AAA rupture
in a patient unfit for re-interventions (see below). The
overall survival rate at 1, 3 and 5 years was 92 2%, 80 3%
and 67 3%, respectively (110 deaths), and mean survival
after EVAR was 91 7 months. The freedom from AAA-
related mortality at the same time points was, respec-
tively, 97 1%, 96 1% and 96 1%.
CT follow-up, AAA diameter and AAA rupture
The 279 patients available for follow-up underwent 1167 CT
scans at a median of 54 months (IQR: 34e74 months)
postoperatively. Five patients abandoned the yearly CT304 patients
279 patients
available for 1-year CT
25 patients unavailable
for 1-year CT
1167 CT-scans
- 23 dead
- 2 conversions to open repair *
Figure 1 Schematic representation of patients included in
EVAR follow-upprotocol.), oneof the conversions to open repair
was performed due to an aorto-duodenal fistula and the patient
died 1.5months later (AAA-related death). All other deaths after
30 days but less than 1 year after EVAR were not related to AAA.follow-up at a median of 44 months (IQR: 18e68 months)
(5-year compliance to follow-up of 99 1%).
AAA expansion was identified in 27 patients at 25 months
(IQR: 24e46 months) postoperatively (expansion-free rate
at 1, 3 and 5 years was, respectively, 100 0%, 94 2% and
88 2%). AAA expansion was neither related to the preop-
erative presence of symptoms (p> 0.05), nor to the
configuration of the stent-graft (p> 0.05).
As described below, 20 of the patients with expanding
AAAs underwent 26 re-interventions (Fig. 2). The remaining
seven patients with expanding AAAs did not receive any re-
intervention, since in six patients the medical condition
was considered too poor (including the two patients
mentioned below with AAA rupture), and one patient
refused the proposed re-intervention and abandoned the
imaging follow-up.
Four patients developed AAA rupture after EVAR. One of
these patients had initially a shrinking AAA, but ruptured
after a separation of the stent-graft limb at 54 months
postoperatively (type III endoleak). The other three
patients had expanding aneurysms at follow-up CT scans
and ruptured at 32, 34 and 73 months after EVAR. One
rupture occurred while waiting for an elective procedure
for endotension and an acute re-intervention was per-
formed (see below). The other two patients were consid-
ered unfit for re-interventions. One of them died upon
rupturing (AAA-related death), while the other patient
survived with a contained rupture until he eventually died
of unrelated cause 2 years later. The causes of rupture in
these last two patients were, respectively, separation of
the bare top stent (type I endoleak) and endotension due to
poor proximal sealing zone.
Re-interventions
The re-intervention-free survival at 1, 3 and 5 years was
92 2%, 84 2% and 77 3%, respectively. Seventy-eight re-
interventionswere performed in 57patients at amedian of 16
(IQR: 3e39) months after EVAR (Fig. 4 provides a schematic
representation of the distribution of re-interventions27 Patients
with expanding AAA
20 patients 
with 26 reinterventions**
7 patients 
without reinterventions
- 6 poor medical candidates*
- 1 refused
Figure 2 Schematic representation of patients with AAA
expansion after EVAR. ), two of the patients that did not
undergo re-interventions due to poor medical conditions
developed contained ruptures. In both cases, AAA expansion
had been identified during the previous CT follow-up. One of
these patients died due to rupture (AAA-related death), while
the other died of an unrelated cause 2 years later. )), two of
the re-interventions were done due to AAA rupture.
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Figure 3 KaplaneMeyer analysis of primary (blue line) and
secondary clinical success (green line). The numbers at risk refer
to the time points immediately above in the figure, that is, 1, 3, 5
and 7 years follow-up.
428 N.V. Dias et al.according to symptoms and is available as extra material in
the internet-based version). Forty patients underwent
a single re-intervention, while 13 patients needed two re-
interventions and four patients required three.
Re-interventions due to endotension were performed in
12 patients (14 re-interventions). The cause for endo-
tension was identified mostly as a failing proximal seal.
Therefore, these patients underwent mainly endovascular
procedures in the proximal neck, with the exception of
three conversions to open surgery. Indications for the
procedures during follow-up are provided in detail as extra
material in the internet-based version of the journal.
CT follow-up and re-interventions prompted by
symptoms
Of the 23 procedures performed due to the development of
symptoms more than 1 month after EVAR, five were per-
formed in patients where the adverse events had already
been suspected in CT follow-up, but the appearance of
symptoms precipitated acute re-interventions: one suffered
rupture, as mentioned above, one aorto-enteric fistula, two
stent-graft infection and one hydronephrosis caused by AAA
inflammatory reaction. The adverse events leading to the
other 18 re-interventions performed in symptomatic patients
had not been suspected by the CT follow-up, since the CT
scans were either negative (nZ 6) or did not focus on the
renal arteries and stent-graft limbs (nZ 5). The remaining
seven of the 18 re-interventions were done 1e12 months
after EVAR and, therefore, no yearly CT scan was available.
Clinical success and benefit from CT follow-up
The primary success rate at 1, 3 and 5 years was 90 2%,
83 2% and 76 2%, respectively. The re-interventions
(described below) allowed a secondary success rate at the
same time intervals of 96 1%, 95 1% and 91 2%,
respectively (Fig. 3). This difference could be attributed to
the benefit conferred by follow-up in 26 out of the 279
(9.3%) patients undergoing routine imaging examinations.
The main findings in the CT scans of these patients were
AAA diameter expansion with or without endoleaks
(nZ 18), kink in the stent-graft limbs (nZ 4), endoleak
type III due to stent-graft limb separation without simul-
taneous AAA expansion (nZ 2), isolated common iliac
artery expansion (nZ 1) and superior mesenteric artery
malperfusion (nZ 1).
Discussion
The follow-up protocols have remained relatively extensive
since the introduction of EVAR in spite of the continuous
stent-graft developments. The CT scan has been the
method of choice for periodic assessments. Our study shows
that the majority of the follow-up CT scans after EVAR do
not lead to re-interventions. Furthermore, the excellent
secondary clinical success rate is achieved by re-interven-
tions that are based mostly on the expansion of the aneu-
rysm or the development of symptoms. This suggests that
asymptomatic patients may have a similar benefit from
simple diameter measurements compared to the one
conferred by the follow-up based on regular CT scans.The tendency of the stent-graft limbs to kink and
separate continued to be a problem after EVAR in this
series. Kinking is expected to decrease in the future, since
it seems to be prevented by liberal intra-operative
stenting of the stent-graft limbs.10 However, the risk for
modular component separation justifies a regular control
of the structural stability of the stent-graft. Plain
abdominal films may suffice for this purpose. Further-
more, plain abdominal films are able to identify material
fatigue such as stent fractures or bare stent separation.
While the first of these complications does not seem to
have clinical consequences with the Zenith stent-
graft,11,12 the second may be fatal as seen in one unfit
patient in this series. The separation of the top bare stent
is, nevertheless, a rare event and is expected to have
been solved by the reinforcement of the suture line after
the year 2002.13
Contrast-enhanced CT scans have been recommended
for follow-up after EVAR, given its good reliability in the
measurement of the AAA diameter and the identification of
endoleaks.1 The routine use of contrast-enhanced CT scans
has, nevertheless, become more controversial. Recent
studies show that CT scan can identify non-aneurysm-
related incidental findings with clinical significance during
the follow-up, but this is more common preoperatively.14
Moreover, repeated CT scans with their inherent ionising
radiation have been suggested to have a carcinogenic
potential.5 This risk may be less relevant in patients
undergoing EVAR, considering their advanced age.
However, aging may enhance the nephrotoxic effects of the
iodine contrast.4
The present study indicates that periodic CT scans after
EVAR benefitted less than 10% of the patients entering the
follow-up program. Furthermore, simple AAA diameter
Is There a Benefit of Frequent CT Follow-up After EVAR? 429measurements, together with control of the structure
stability of the stent-graft, would identify the majority of
asymptomatic patients requiring a re-intervention. In the
present study, the use of simple aorto-iliac diameter
measurements instead of contrast-enhanced CT scans
would most likely only postpone the identification of
a superior mesenteric artery malperfusion in a patient with
a pelvic renal transplant, where both native renal arteries
were covered by the stent-graft. Simple diameter
measurements can be done by CT scans with selective
contrast injection only when adverse events were sus-
pected. CT scan allows also the measurement of the
aneurysm volume, which has been suggested to be advan-
tageous although it is still a time-consuming method.15
However, this assessment also seems to be safely done by
ultrasound,16,17 which has the additional advantage of
decreasing the costs associated with the imaging follow-
up,6,7 and thereby increasing the cost-effectiveness of
EVAR.18 Similar conclusions were made in a recently pub-
lished study suggesting that postoperative CT scans may be
abandoned after more than 1 year postoperatively in
patients free from endoleaks.19 Nevertheless, if ultrasound
becomes the method of choice for the routine follow-up
after standard infrarenal EVAR, contrast-enhanced CT scan
continues to be fundamental whenever adverse events are
suspected. This becomes even more relevant when the
background risk for rupture is higher, that is, in patients
with extremely large AAAs.
Some other issues need to be addressed in this study:
Zenith stent-graftswere exclusively used and, therefore, the
conclusions can only be applied to this endoprosthesis.
Furthermore, during the study period, we have introduced
fenestrated stent-grafts into our clinical practice. The good
results of these endoprostheses in patients with challenging
aneurysmnecks20,21may further improve the results of EVAR.
This effect is expected to occur even in patients receiving
standard infrarenal stent-grafts, since these prostheses will
be limited to patientswith a good anatomy, as opposed to the
current material where 20% of the patients had an aneurysm
neck anatomy that did not comply with the recommenda-
tions of the manufacturer. These broad criteria for the
acceptance for EVAR may be one of the reasons for the
occurrence of endotension, which was usually associated
with failure of the proximal seal.
This study excluded patients being treated for ruptured
AAAs in order to avoid the inclusion of aneurysms without
an intact wall, which may condition the remodelling after
EVAR and thereby the diameter assessment. Moreover,
and more importantly, in ruptured AAAs, the choice of
the stent-graft is limited by the existing local stock and the
emergency of the procedure, which may condition the
clinical results later on.
One drawback of this study has been the changes in the
frequency of the imaging follow-up during the study period.
However, this does not seem to have greatly changed the
results since the majority of the adverse events leading to
re-interventions in symptomatic patients had not been
suspected in the previous CT follow-up. This suggests the
safety of yearly controls when current stent-grafts have
been used.
In conclusion, less than 10% of the patients being followed
up after EVAR of AAAwith the Zenith stent-graft benefit fromperiodic CT follow-up, evenwhen broad inclusion criteria for
the aneurysm neck are applied. This benefit would most
likely be sustained by a follow-up protocol based on the
combined use of measurements of aneurysm diameter by
simple ultrasound and plain abdominal films. This would
simplify the follow-up protocol and also reduce the patients’
exposure to radiation and nephrotoxic contrast. TheCTscans
should, nevertheless, continue to be used at 1 year after
EVAR or whenever an adverse event is suspected and a re-
intervention is planned.
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